Myrthe L. Verburgh
YOU?
Author Swipe
View article: Stigma-Related Disclosure Concerns and Negative Self-Image Have Not Improved Over a Decade in Older People With HIV
Stigma-Related Disclosure Concerns and Negative Self-Image Have Not Improved Over a Decade in Older People With HIV Open
Objective: Stigma impedes the HIV care continuum and contributes to problematic mental health outcomes, nonadherence, and reduced quality of life. We prospectively analyzed changes in HIV stigma measures for 10 years among older people wit…
View article: The expected impact of a cure for HIV among people with HIV and key populations
The expected impact of a cure for HIV among people with HIV and key populations Open
View article: The Expected Impact of HIV Post-Treatment Control and HIV Elimination on Quality of Life, Sexual Satisfaction, and Stigma Among People With HIV and Key Populations
The Expected Impact of HIV Post-Treatment Control and HIV Elimination on Quality of Life, Sexual Satisfaction, and Stigma Among People With HIV and Key Populations Open
Objective This study explored the expected impact of two hypothetical HIV cure scenarios on quality of life (QoL), sexual satisfaction, and stigma among people with HIV (PHIV) and key populations (i.e., partners of PHIV, family members, fr…
View article: Similar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls
Similar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls Open
Background Little is known about the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron infection in people with human immunodeficiency virus (HIV; PWH) with vaccine-induced or hybrid immunity. We assessed the inc…
View article: Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV
Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV Open
View article: No evidence of rapid reversibility of tenofovir alafenamide and/or integrase strand transfer inhibitor-associated weight gain
No evidence of rapid reversibility of tenofovir alafenamide and/or integrase strand transfer inhibitor-associated weight gain Open
Objective: We aimed to determine the reversibility of at least 7% weight gain within 12 months following tenofovir alafenamide (TAF) and/or integrase strand transfer inhibitor (INSTI) discontinuation in people with HIV (PWH) from the Dutch…
View article: Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV
Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV Open
Some studies have suggested that people with HIV may respond less well to vaccines against SARS-CoV-2. We comprehensively compared B- and T-cell responses to different COVID-19 vaccines in middle-aged persons with well-treated HIV and indi…
View article: No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands
No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands Open
In two Dutch observational cohorts of people with HIV, the use of TDF, ETR, or INSTIs was not independently associated with either the risk of incident SARS-CoV-2 infection or severe COVID-19 outcomes, as was suggested by previous observat…
View article: Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV
Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV Open
Background: Little is known about the impact of social distancing on health-related quality of life and depressive symptoms in older people with HIV during the COVID-19 pandemic. Setting: HIV-positive and HIV-negative AGE h IV Cohort Study…
View article: One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor
One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor Open
Background We determined the frequency of and factors associated with ≥10% weight gain and its metabolic effects in virally suppressed people with human immunodeficiency virus (PWH) from the Dutch national AIDS Therapy Evaluation in the Ne…
View article: Long-Term Trends in Comorbidity Evolution and Disease Burden in HIV-Positive Compared to HIV-Negative Individuals as They Age
Long-Term Trends in Comorbidity Evolution and Disease Burden in HIV-Positive Compared to HIV-Negative Individuals as They Age Open
View article: Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People With Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIV
Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People With Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIV Open
Background Within the ongoing AGEhIV Cohort Study in Amsterdam, we prospectively compared the incidence of and risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection between human immunodeficiency virus (HI…